Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function.
Ortega FJ, Moreno-Navarrete JM, Mercader JM, Gómez-Serrano M, García-Santos E, Latorre J, Lluch A, Sabater M, Caballano-Infantes E, Guzmán R, Macías-González M, Buxo M, Gironés J, Vilallonga R, Naon D, Botas P, Delgado E, Corella D, Burcelin R, Frühbeck G, Ricart W, Simó R, Castrillon-Rodríguez I, Tinahones FJ, Bosch F, Vidal-Puig A, Malagón MM, Peral B, Zorzano A, Fernández-Real JM. Ortega FJ, et al. Among authors: buxo m. FASEB J. 2019 Aug;33(8):9656-9671. doi: 10.1096/fj.201900479R. Epub 2019 May 30. FASEB J. 2019. PMID: 31145872 Free article.
Collectively, current findings highlight the contribution of cytoskeletal TAGLN2 to the obese phenotype in a gender-dependent manner.-Ortega, F. J., Moreno-Navarrete, J. M., Mercader, J. M., Gomez-Serrano, M., Garcia-Santos, E., Latorre, J., Lluch, A., Sabate …
Collectively, current findings highlight the contribution of cytoskeletal TAGLN2 to the obese phenotype in a gender-dependent manner.-Ortega …
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
Muñoz-San Martín M, Gómez I, Quiroga-Varela A, Gonzalez-Del Río M, Robles Cedeño R, Álvarez G, Buxó M, Miguela A, Villar LM, Castillo-Villalba J, Casanova B, Quintana E, Ramió-Torrentà L. Muñoz-San Martín M, et al. Among authors: buxo m. Neurol Neuroimmunol Neuroinflamm. 2022 Dec 9;10(1):e200069. doi: 10.1212/NXI.0000000000200069. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36724195 Free PMC article.
Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.
Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L. Muñoz-San Martín M, et al. Among authors: buxo m. J Neuroinflammation. 2019 Nov 14;16(1):220. doi: 10.1186/s12974-019-1590-5. J Neuroinflammation. 2019. PMID: 31727077 Free PMC article.
Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona.
Ameijide A, Clèries R, Carulla M, Buxó M, Marcos-Gragera R, Martínez JM, Vilardell ML, Vilardell M, Espinàs JA, Borràs JM, Izquierdo Á, Galceran J. Ameijide A, et al. Among authors: buxo m. Clin Transl Oncol. 2019 Aug;21(8):1014-1025. doi: 10.1007/s12094-018-02015-5. Epub 2019 Jan 3. Clin Transl Oncol. 2019. PMID: 30607790 Free article.
Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.
Quintana E, Coll C, Salavedra-Pont J, Muñoz-San Martín M, Robles-Cedeño R, Tomàs-Roig J, Buxó M, Matute-Blanch C, Villar LM, Montalban X, Comabella M, Perkal H, Gich J, Ramió-Torrentà L. Quintana E, et al. Among authors: buxo m. Eur J Neurol. 2018 Sep;25(9):1189-1191. doi: 10.1111/ene.13687. Epub 2018 Jun 22. Eur J Neurol. 2018. PMID: 29797629
Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers.
Muñoz-San Martín M, Torras S, Robles-Cedeño R, Buxó M, Gomez I, Matute-Blanch C, Comabella M, Villar LM, Perkal H, Quintana E, Ramió-Torrentà L. Muñoz-San Martín M, et al. Among authors: buxo m. Epigenomics. 2020 Dec;12(23):2065-2076. doi: 10.2217/epi-2020-0172. Epub 2020 Dec 8. Epigenomics. 2020. PMID: 33290101
Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis.
Coll-Martinez C, Quintana E, Salavedra-Pont J, Buxó M, González-Del-Rio M, Gómez I, Muñoz-San Martín M, Villar LM, Álvarez-Bravo G, Robles-Cedeño R, Ramió-Torrentà L, Gich J. Coll-Martinez C, et al. Among authors: buxo m. Brain Behav. 2021 Dec;11(12):e2405. doi: 10.1002/brb3.2405. Epub 2021 Nov 18. Brain Behav. 2021. PMID: 34796675 Free PMC article.
Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly.
Clèries R, Ameijide A, Marcos-Gragera R, Pareja L, Carulla M, Vilardell ML, Esteban L, Buxó M, Espinàs JA, Puigdefàbregas A, Ribes J, Izquierdo A, Galceran J, Borrás JM. Clèries R, et al. Among authors: buxo m. Clin Transl Oncol. 2018 May;20(5):647-657. doi: 10.1007/s12094-017-1764-5. Epub 2017 Oct 12. Clin Transl Oncol. 2018. PMID: 29027110 Free article.
72 results